After decades of investigation, gene therapy has received regulatory approval to treat hemophilia. However,...
Read More
Primary prophylaxis has significantly reduced the number of orthopedic surgical procedures performed on patients...
The standard of care in severe haemophilia A is prophylaxis, which has historically aimed...
Data from 21 years (2000–2020) of haemovigilance were used to assess human immunodeficiency virus (HIV),...
Occult hepatitis B (HBV) infection (OBI), characterized by low viral loads, accounts for much...
Hemophilia A is characterized by a deficiency of clotting factor VIII (FVIII) requiring lifelong...
Gene therapy is expected to become a promising treatment, and potentially even cure, for hemophilia....
Over the last decade, the world of hemophilia has experienced an unprecedented therapeutic advance,...
New treatment possibilities and modalities are now available globally for patients with haemophilia requiring...
Abstract: Background: Intracranial hemorrhage (ICH) is a highly serious event in patients with haemophilia...